Antiplatelet Therapy for Secondary Prevention of Vascular Disease Complications

被引：0

作者：

Rahul R. Goli

Mayur M. Contractor

Ashwin Nathan

Sony Tuteja

Taisei Kobayashi

Jay Giri

机构：

[1] Hospital of University of Pennsylvania,Division of Cardiovascular Medicine

[2] Smilow Center for Translational Research,undefined

[3] Hospital of the University of Pennsylvania,undefined

来源：

Current Atherosclerosis Reports | 2017年 / 19卷

关键词：

Antiplatelet therapy; Secondary prevention; Vascular disease; Cardiovascular; Aspirin; Clopidogrel; Ticagrelor;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[31] Antiplatelet therapy in secondary stroke prevention - state of the art
Diener, Hans-Christoph
Weimar, Christian
Weber, Ralph
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2010, 14 (11) : 2552 - 2560
[32] Antiplatelet Therapy for Secondary Prevention of Cerebrovascular Disease (vol 27, pg 208, 2011)
Bell, A. D.
Roussin, A.
Cartier, R.
Chan, W. S.
Douketis, J. D.
CANADIAN JOURNAL OF CARDIOLOGY, 2011, 27 (05) : 663 - 663
[33] Prevention of vascular events in patients with cerebrovascular disease: Efficacy and appropriate duration of antiplatelet therapy
Habib, GB
CLINICAL CARDIOLOGY, 2006, 29 (06) : 244 - 248
[34] Dual antiplatelet therapy in secondary prevention for coronary and cerebrovascular disease and thrombocytopenia: A Systematic Review
Manrique-Samer, Mauricio
Ibanez-Gamboa, Marcela F.
Cita-Pardo, Jose E.
Munoz-Velandia, Oscar M.
REVISTA DE LA FEDERACION ARGENTINA DE CARDIOLOGIA, 2025, 54 (01): : 25 - 32
[35] The 2020 breakthroughs in early secondary prevention: dual antiplatelet therapy versus single antiplatelet therapy
Kargiotis, Odysseas
Tsivgoulis, Georgios
CURRENT OPINION IN NEUROLOGY, 2021, 34 (01) : 45 - 54
[36] Optimal oral antiplatelet therapy for vascular disease
不详
JOURNAL OF FAMILY PRACTICE, 2005, 54 (01): : 23 - 23
[37] Antiplatelet Therapy in Coronary Heart Disease Prevention
Kolandaivelu, Kumaran
Bhatt, Deepak L.
CARDIOLOGY CLINICS, 2011, 29 (01) : 71 - +
[38] Systematic review of antiplatelet therapy for the prevention of myocardial infarction, stroke or vascular death in patients with peripheral vascular disease
Robless, P
Mikhailidis, DP
Stansby, G
BRITISH JOURNAL OF SURGERY, 2001, 88 (06) : 787 - 800
[39] Secondary Prevention of Cardiovascular Disease With Vorapaxar A New Era of 3-Drug Antiplatelet Therapy?
Krantz, Mori J.
Kaul, Sanjay
JAMA INTERNAL MEDICINE, 2015, 175 (01) : 9 - 10
[40] Dual Antiplatelet Therapy with Clopidogrel and Aspirin for Secondary Stroke Prevention
Yilong Wang
Weiqi Chen
Yongjun Wang
Current Cardiology Reports, 2015, 17

← 1 2 3 4 5 →